Loading...

Fidson Healthcare Plc – H1 2025

Published
12 Feb 25
Updated
24 Sep 25
WaneInvestmentHouse's Fair Value
₦35.00
22.9% overvalued intrinsic discount
24 Sep
₦43.00
Loading
1Y
173.0%
7D
0%

Author's Valuation

₦35

22.9% overvalued intrinsic discount

WaneInvestmentHouse's Fair Value

Shared on24 Sep 25
Fair value Increased 13%

Fidson Healthcare Plc — Expanded Partnership with Ohara Pharmaceutical Event Summary Fidson Healthcare Plc signed a Memorandum of Understanding (MoU) with Japan’s Ohara Pharmaceutical Co. Ltd at TICAD9 in Tokyo. The MoU builds on their 2019 strategic alliance , when Ohara acquired a 21.75% stake in Fidson via a Rights Issue.

Shared on31 Jul 25
Fair value Increased 29%

Valuation as at recent H1 Result

Shared on30 Jul 25

WaneInvestmentHouse has decreased revenue growth from 12.5% to 5.2% and decreased shares outstanding growth rate from 0.1% to 0.0%.

Shared on05 May 25

WaneInvestmentHouse has increased revenue growth from 5.1% to 12.5%.

Shared on02 Apr 25
Fair value Decreased 46%

WaneInvestmentHouse has decreased revenue growth from 46.4% to 5.1% and increased profit margin from 6.0% to 12.0%.